IdentifySensors
  • Press Room
  • About
  • Contact
Select Page
IDENTIFYSENSORS OPENS NEW LABORATORY TO SUPPORT PRODUCT EXPANSION AND MANUFACTURING

IDENTIFYSENSORS OPENS NEW LABORATORY TO SUPPORT PRODUCT EXPANSION AND MANUFACTURING

by Rhett Butler | May 19, 2023 | Biologics, Press

FORMER LUCIRA EVP AND CQO JOINS IDENTIFYSENSORS AS EVP AND CHIEF QUALITY OFFICER Article Source: https://identifysensors.com   Ghazi Kashmolah to direct manufacturing & FDA compliance for digital diagnostic platform. CLEVELAND – IdentifySensors ® Biologics, the...
IDENTIFYSENSORS ADDS FOUR REGULATORY AND QUALITY EXPERTS TO MOVE NEW TECHNOLOGY TO COMMERCIALIZATION

IDENTIFYSENSORS ADDS FOUR REGULATORY AND QUALITY EXPERTS TO MOVE NEW TECHNOLOGY TO COMMERCIALIZATION

by Rhett Butler | Apr 2, 2023 | Biologics, Press

IDENTIFYSENSORS ADDS FOUR REGULATORY AND QUALITY EXPERTS TO MOVE NEW TECHNOLOGY TO COMMERCIALIZATION Article Source:   Read More MEDIA & PRESS INQUIRES CONNECT WITH IDENTIFYSENSORS Communications: Joe Mosbrook(216) 375-2141mosbrook@acclaimllc.com Related...
FORMER LUCIRA EVP AND CQO JOINS IDENTIFYSENSORS AS EVP AND CHIEF QUALITY OFFICER

FORMER LUCIRA EVP AND CQO JOINS IDENTIFYSENSORS AS EVP AND CHIEF QUALITY OFFICER

by Rhett Butler | Feb 21, 2023 | Biologics, Press

FORMER LUCIRA EVP AND CQO JOINS IDENTIFYSENSORS AS EVP AND CHIEF QUALITY OFFICER Article Source: https://identifysensors.com   Ghazi Kashmolah to direct manufacturing & FDA compliance for digital diagnostic platform. CLEVELAND – IdentifySensors ® Biologics, the...
IDENTIFYSENSORS BIOLOGICS REACHES BREAKTHROUGH SENSITIVITY LEVELS WITH NEW DIGITAL DIAGNOSTICS PLATFORM

IDENTIFYSENSORS BIOLOGICS REACHES BREAKTHROUGH SENSITIVITY LEVELS WITH NEW DIGITAL DIAGNOSTICS PLATFORM

by Rhett Butler | Jan 4, 2023 | App, Biologics, Check4, Covid, Press

IDENTIFYSENSORS BIOLOGICS REACHES BREAKTHROUGH SENSITIVITY LEVELS WITH NEW DIGITAL DIAGNOSTICS PLATFORM Article Source: https://identifysensors.com   Digital testing on saliva exceeds PCR sensitivity for immediate early detection and treatment. CLEVELAND –...
IDENTIFYSENSORS HAS FINALIZED PROOF-OF-CONCEPT RESEARCH FOR ALL-NEW COVID TESTING METHOD

IDENTIFYSENSORS HAS FINALIZED PROOF-OF-CONCEPT RESEARCH FOR ALL-NEW COVID TESTING METHOD

by Rhett Butler | Feb 2, 2022 | App, Biologics, Check4, Covid, Press

IDENTIFYSENSORS HAS FINALIZED PROOF-OF-CONCEPT RESEARCH FOR ALL-NEW COVID TESTING METHOD Article Source: https://www.360dx.com   NEW YORK – A new COVID-19 test that relies on graphene sensors and electric currents to return results in minutes could be on the market...
IDENTIFYSENSORS BIOLOGICS RECEIVES TECHOHIO START-UP AWARD

IDENTIFYSENSORS BIOLOGICS RECEIVES TECHOHIO START-UP AWARD

by Rhett Butler | Aug 17, 2021 | App, Biologics, Check4, Covid, Press

IDENTIFYSENSORS BIOLOGICS RECEIVES TECHOHIO START-UP AWARD Article Source:  August 17, 2021  App, Biologics, Check4, Covid, Press Cleveland – IdentifySensors Biologics, along with leading researchers at Purdue University, developed a breakthrough...
« Older Entries

Categories

  • App
  • Biologics
  • Check4
  • Covid
  • Press

Tags

Biologics Check4 Covid Self-Test Team Technology
Press Room

MEDIA & PRESS INQUIRES

Communications: Joe Mosbrook
(216) 375-2141
mosbrook@acclaimllc.com

Find out more about our Patents & Technologies

Request
Information

This site is protected by reCAPTCHA and the Google
Privacy Policy and Terms of Service apply.
identifysensors company logo

COMPANY

ABOUT US

Leadership

CONTACT

Privacy

FACEBOOK
LINKEDIN
YOUTUBE

DISCLAIMER:

THE OFFERING MATERIALS MAY CONTAIN FORWARD-LOOKING STATEMENTS AND INFORMATION RELATING TO, AMONG OTHER THINGS, THE COMPANY, ITS BUSINESS PLAN AND STRATEGY, AND ITS INDUSTRY. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON THE BELIEFS OF, ASSUMPTIONS MADE BY, AND INFORMATION CURRENTLY AVAILABLE TO THE COMPANY’S MANAGEMENT. WHEN USED IN THE OFFERING MATERIALS, THE WORDS “ESTIMATE,” “PROJECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “EXPECT” AND SIMILAR EXPRESSIONS ARE INTENDED TO IDENTIFY FORWARD-LOOKING STATEMENTS, WHICH CONSTITUTE FORWARD LOOKING STATEMENTS. THESE STATEMENTS REFLECT MANAGEMENT’S CURRENT VIEWS WITH RESPECT TO FUTURE EVENTS AND ARE SUBJECT TO RISKS AND UNCERTAINTIES THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE CONTAINED IN THE FORWARD-LOOKING STATEMENTS. INVESTORS ARE CAUTIONED NOT TO PLACE UNDUE RELIANCE ON THESE FORWARD-LOOKING STATEMENTS, WHICH SPEAK ONLY AS OF THE DATE ON WHICH THEY ARE MADE. THE COMPANY DOES NOT UNDERTAKE ANY OBLIGATION TO REVISE OR UPDATE THESE FORWARD-LOOKING STATEMENTS TO REFLECT EVENTS OR CIRCUMSTANCES AFTER SUCH DATE OR TO REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.

THE COMPANY IS RAISING CAPITAL FOR EXPANSION VIA an offering exempt from registration under Regulation A. FOR DETAILS, VISIT THE COMPANY’S INVESTMENT PAGE.

AN OFFERING STATEMENT REGARDING THIS OFFERING HAS BEEN FILED WITH THE SEC. THE SEC HAS QUALIFIED THAT OFFERING STATEMENT, WHICH ONLY MEANS THAT THE COMPANY MAY MAKE SALES OF THE SECURITIES DESCRIBED BY THE OFFERING STATEMENT. IT DOES NOT MEAN THAT THE SEC HAS APPROVED, PASSED UPON THE MERITS OR PASSED UPON THE ACCURACY OR COMPLETENESS OF THE INFORMATION IN THE OFFERING STATEMENT. Offers and sales of our securities are made only by the offering circular. YOU MAY OBTAIN A COPY OF THE OFFERING CIRCULAR THAT IS PART OF THAT OFFERING STATEMENT FROM: ISB-Updated-offering-circular-03.10.2021.pdf

YOU SHOULD READ THE OFFERING CIRCULAR BEFORE MAKING ANY INVESTMENT.

©2021 IDENTIFYSENSORS, LLC, ALL RIGHTS RESERVED.

Privacy Settings